MedPath

CEFOTAXIME SODIUM FOR INJECTION, BP

CEFOTAXIME SODIUM FOR INJECTION, BP

Approved
DIN Number

02434091

Drug Class

Human

Market Date

Mar 12, 2015

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02434091
AIG Number0152507001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD01 CEFOTAXIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFOTAXIME SODIUMActive
Strength: 1 G / VIAL
Monograph: CEFOTAXIME SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.